Key result
Cardiovascular amplitude measured by wearable devices follows a predictable pattern across the menstrual cycle, offering a potential non-invasive proxy for monitoring female hormonal fluctuations.
Answers are grounded in this paper and cite their sources.
This commentary highlights 'cardiovascular amplitude' as a promising wearable-derived metric to non-invasively monitor female hormonal fluctuations and cardiovascular health across the menstrual cycle, while emphasizing the need for direct hormonal validation and stronger data privacy protections.
Cardiovascular disease is underdiagnosed and undertreated in women compared to men. Wearable technologies (wearables) help shed light on women’s cardiovascular by collecting continuous cardiovascular data and correlating it with hormonal fluctuations across the menstrual cycle. In this context, Jasinski et al. propose that the new metric, cardiovascular amplitude, enables non-invasive monitoring of female physiology and health across the menstrual cycle.
No takes yet. Share an insight, caveat, or question.
Heydari et al. (2025) conducted an editorial in Cardiovascular health and menstrual regularity in women. Cardiovascular amplitude monitoring via wearable technologies was evaluated. Cardiovascular amplitude measured by wearable devices follows a predictable pattern across the menstrual cycle, offering a potential non-invasive proxy for monitoring female hormonal fluctuations.
Synapse has enriched 10 related papers. Consider them for comparative context: